The US health regulatory agency on Wednesday authorised the world's first respiratory syncytial virus (RSV) vaccine. The Food and Drug Administration said that GlaxoSmithKline Biologicals' Arexvy vaccine can help protect people over 60 from RSV health risks. "Older adults, in particular those with u...